  Purpose: The purpose of the present article is to propose a modified version
of the D-shaped collimator used at the Univ. Hosp. of Essen for retinoblastoma
treatment that reduces even further the irradiation field with the scope to
reduce the risk of radio-induced secondary malignancies. The new dedicated
D-shaped collimator is easier to build and produces dose distributions that
only differ on the field size with respect to the dose distributions obtained
by the current collimator in use.
  Methods: The Monte Carlo code PENELOPE was used to study the effect that the
structural elements of the collimator have on the absorbed dose distribution.
The radiation transport through a Varian Clinac 2100 C/D operating at 6MV was
simulated in order to tally phase-space files which were used as radiation
sources to simulate the considered collimators and the subsequent dose
distributions.
  Results: The proposed collimator delivers a dose distribution which is 2.4cm
wide along the inferior-superior direction of the eyeball. This width is 0.3cm
narrower than that of the dose distribution obtained with the collimator
currently in use. The other relevant characteristics of the dose distribution
obtained with the new collimator, namely, depth doses, penumbrae width and
shape of the lateral profiles, are statistically compatible with the results
obtained for the collimator in use.
  Conclusions: The smaller field size delivered by the proposed collimator
still fully covers the planning target volume with at least 95% of the maximum
dose at a depth of 2cm and provides a safety margin of 0.2cm, so ensuring an
adequate treatment while reducing the dose absorbed by surrounding structures
of the eye.
